|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis显示文摘 | Laurent Dubuquoy Emmelie ? Jansson Samir Deeb Sabine Rakotobe Mehdi Karoui Jean-Frédéric Colombel Johan Auwerx Sven Pettersson Pierre Desreumaux | 2003 | Gastroenterology2003,,5: | 2 |
| 2 | End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients显示文摘AIM To determine if end-stage renal disease (ESRD) is a risk factor for post endoscopic retrograde cholangio-pancreatography (ERCP) adverse events (AEs). METHODS We performed a retrospective cohort study using the Nationwide Inpatient Sample (NIS) 2011-2013. We identified adult patients who underwent ERCP using the International Classification of Diseases 9^(th) Revision (ICD-9-CM). Included patients were divided into three groups: ESRD, chronic kidney disease (CKD), and control. The primary outcome was post-ERCP AEs including pancreatitis, bleeding, and perforation determined based on specific ICD-9-CM codes. Secondary outcomes were length of hospital stay, in-hospital mortality, and admission cost. AEs and mortality were compared using multivariate logistic regression analysis.RESULTS There were 492175 discharges that underwent ERCP during the 3 years. The ESRD and CKD groups contained 7347 and 39403 hospitalizations respectively, whereas the control group had 445424 hospitalizations. Post-ERCP pancreatitis (PEP) was significantly higher in the ESRD group (8.3%) compared to the control group (4.6%) with adjusted odd ratio (aOR) = 1.7 (95% CI: 1.4-2.1, ~aP < 0.001). ESRD was associated with significantly higher ERCP-related bleeding (5.1%) compared to the control group 1.5% (aOR = 1.86, 95%CI: 1.4-2.4, ~aP < 0.001). ESRD had increased hospital mortality 7.1% vs 1.15% in the control OR = 6.6 (95%CI: 5.3-8.2, ~aP < 0.001), longer hospital stay with adjusted mean difference (aMD) = 5.9 d (95% CI: 5.0-6.7 d, ~aP < 0.001) and higher hospitalization charges aMD = $+82064 (95%CI: $68221-$95906, ~aP < 0.001). CONCLUSION ESRD is a risk factor for post-ERCP AEs and is associated with higher hospital mortality. Careful selection and close monitoring is warranted to improve outcomes. | Tarek Sawas Fateh Bazerbachi Samir Haffar Won K Cho Michael J Levy John A Martin Bret T Petersen Mark D Topazian Vinay Chandrasekhara Barham K Abu Dayyeh | 2018 | World Journal of Gastroenterology2018,24,41: | 2 |
| 3 | Frozenshoulder显示文摘 | Riehard D Steven C Samir M | 2005 | BMJ2005,331,7530: | 1 |
| 4 | Endoscopically Assisted Sural Nerve Harvest for Upper Extremity Posttraumatic Nerve Defects: An Evaluation of Functional Outcomes 显示文摘 | LIN CHIH - HUNG M D MARDINI SAMIR M D | 2007 | Plastic & Reconstructive Surgery2007,119,2: | 1 |
| 5 | The prevalence and predictive value of abnormal preoperative lavoratiry test in elderly surgical patients显示文摘 | Samir D Darwin P Carlos G | 2002 | Anesthesia and Analgesia2002,3,1: | 1 |
| 6 | A Fast Elitist Non-dominated Sorting Genetic Algorithm for Multiobjective Optimization:NSGA-II显示文摘 | Kalyanmoy D Samir A Amrit P | 2002 | IEEE Transactions on Evolutionary Computation2002,6,2: | 1 |
| 7 | Serial changes in left ventricular function after coronary bypass implication in viability assessment显示文摘 | Massroor G Samir D Virgijia C | 1995 | Am Heart J1995,129,: | 1 |
| 8 | Effect of moisture and temperature on the mechanical properties of concrete显示文摘 | Samir N S Gergis W W Brian D | 2011 | Construction and Building Materials2011,25,2: | 1 |
| 9 | Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis显示文摘 | Samir S Taneja Elias I Hsu Carol D Cheli Paul Walden Georg Bartsch Wolfgang Horninger Richard J Babaian Herbert A Fritsche Stacy Childs Thomas A Stamey Lori J Sokoll Daniel W Chan Michael K Brawer Alan W Partin Herbert Lepor | 2002 | Urology2002,,4: | 1 |
| 10 | Prosthetic valve thrombosis with adequate anticoagulation显示文摘 | Malek M Samir A Habib A D | | 0,,03: | 1 |
| 11 | Minimum inter- ference channel assignment in multi-radio wireless mesh networks 显示文摘 | Anandprabhu S Himanshu G Samir R D | 2008 | Mobile Computing2008,7,12: | 1 |
| 12 | Comprehensive modeling of mat density effect on duckweed ( Lemna minor ) growth under controlled eutrophication显示文摘 | Monette Frédéric Lasfar Samir Millette Louise Azzouz Abdelkrim | 2006 | Water Research2006,,15: | 1 |
| 13 | Selective boron drug delivery to brain tumors for boron neutron capture therapy显示文摘 | C Wei C Samir D Mehta | 1997 | Advanced Drug Delivery Reviews1997,26,: | 1 |
| 14 | Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular-patterned Lesions of the Thyroid: Diagnostic Accuracy and Optimal Measurement Plane 显示文摘 | Samir AE Manish D Arash A | 2015 | Radiology2015,277,2: | 1 |
| 15 | Characterization of anti-N-acetyl-d-glucosamine antibodies elicited through haptenated liposomes 显示文摘 | Manoj K D Samir K R Debi P S | 1984 | Carbohydrate Research1984,128,2: | 1 |
| 16 | Effect of metal salt on the pore structure evolution of pitch-based activated carbon microfibers 显示文摘 | Samir H Mushrif Alejandro Rey D | 2008 | Industrial & Engineering Chemistry Research2008,47,11: | 1 |
| 17 | Can short-term fasting protect against doxorubicin-induced cardiotoxicity?显示文摘Doxorubicin(Dox) is one of the most effective chemotherapeutic agents used in the treatment of several types of cancer. However the use is limited by cardiotoxicity. Despite extensive investigation into the mechanisms of toxicity and preventative strategies, Dox-induced cardiotoxicity still remains a major cause of morbidity and mortality in cancer survivors. Thus, continued research into preventative strategies is vital. Short-term fasting has proven to be cardioprotective against a variety of insults. Despite the potential, only a few studies have been conducted investigating its ability to prevent Dox-induced cardiotoxicity. However, all show proof-of-principle that short-term fasting is cardioprotective against Dox. Fasting affects a plethora of cellular processes making it difficult to discern the mechanism(s) translating fasting to cardioprotection, but may involve suppression of insulin and insulin-like growth factor-1 signaling with stimulated autophagy. It is likely that additional mechanisms also contribute. Importantly, the literature suggests that fasting may enhance the antitumor activity of Dox. Thus, fasting is a regimen that warrants further investigation as a potential strategy to prevent Dox-induced cardiotoxicity. Future research should aim to determine the optimal regimen of fasting, confirmation that this regimen does not interfere with the antitumor properties of Dox, as well as the underlying mechanisms exerting the cardioprotective effects. | Amie J Dirks-Naylor Samir A Kouzi Sendra Yang Ngan TK Tran Joseph D Bero Raean Mabolo Diep T Phan Stephanie D Whitt Heather N Taylor | 2014 | World Journal of Biological Chemistry2014,5,3: | 1 |
| 18 | The view-based approach to dynamic inter-organizational workflow cooperation 显示文摘 | ISSAM C SCHAHRAM D SAMIR T | 2006 | Data and Knowledge Engineering2006,56,2: | 1 |
| 19 | 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial显示文摘 | Samir R Kapadia Martin B Leon Raj R Makkar E Murat Tuzcu Lars G Svensson Susheel Kodali John G Webb Michael J Mack Pamela S Douglas Vinod H Thourani Vasilis C Babaliaros Howard C Herrmann Wilson Y Szeto Augusto D Pichard Mathew R Williams Gregory P Fontan | 2015 | The Lancet . 2015 (9986)2015,,: | 1 |
| 20 | 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial显示文摘 | Michael J Mack Martin B Leon Craig R Smith D Craig Miller Jeffrey W Moses E Murat Tuzcu John G Webb Pamela S Douglas William N Anderson Eugene H Blackstone Susheel K Kodali Raj R Makkar Gregory P Fontana Samir Kapadia Joseph Bavaria Rebecca T Hahn Vinod H | 2015 | The Lancet . 2015 (9986)2015,,: | 1 |